Nuclear Magnetic Resonance (NMR) Spectroscopy

Nuclear Magnetic Resonance (NMR) Spectroscopy is a gold-standard label-free biophysical technique dedicated to hit identification and validation in early drug discovery. Unlike functional screening methods, NMR directly characterizes target-ligand interactions in native physiological environments, enabling the detection of weak to moderate affinity binders and providing detailed structural insights into binding modes and active sites.

NMR hit screening relies on detecting chemical shift perturbations, signal intensity changes or relaxation rate variations of target proteins or ligand molecules upon binding. This non-invasive, label-free approach delivers unique and irreplaceable value for hit discovery, especially for challenging drug targets:

• Label-Free & Non-Destructive Detection: Requires no fluorescent, radioactive or chemical modifications, preserving the native conformation of target proteins and ligands to ensure authentic, physiologically relevant binding interactions, eliminating false results caused by probe interference.
• Capture Weak-Affinity Binders: Excels at detecting low-affinity fragment hits and weak binders that are often missed by HTS, expanding the pool of potential hits and providing more starting points for lead optimization, particularly vital for PPI targets, GPCRs and ion channels.
• Structural Binding Insights: Not only identifies active hits but also locates ligand binding sites, characterizes binding modes and quantifies binding affinity, offering critical structural data to guide hit-to-lead progression and structure-activity relationship (SAR) analysis.
• Wide Target Applicability: Adaptable to soluble proteins, membrane proteins, multi-subunit complexes and nucleic acid targets, supporting hit screening across oncology, immunology, metabolic disorders and infectious disease therapeutic areas.
• High Specificity & Accuracy: Delivers precise detection of target-ligand binding, effectively excluding non-specific binders, significantly improving the quality of hit compounds and reducing late-stage development risks.

As a core brand of STEMart, PharmaAnalytica delivers customized NMR hit screening services for global pharmaceutical, biotech firms and academic research teams. Leveraging high-field NMR spectrometers, automated sample processing systems and professional data analysis pipelines, we efficiently identify high-confidence hit compounds from fragment libraries, small molecule libraries and natural product libraries, addressing screening bottlenecks for intractable targets and laying a solid foundation for subsequent lead optimization and drug development.

Standard NMR Hit Screening Workflow

PharmaAnalytica adheres to a strict 4-phase standardized NMR screening workflow, guaranteeing efficient, accurate and reliable identification of high-quality hit compounds for drug discovery projects:

1. Target Preparation & Assay Optimization: Purify and label target proteins as needed, optimize buffer systems, temperature and pH conditions, and validate target stability and solubility to establish a robust NMR screening platform.
2. Sample Incubation & Batch Processing: Incubate target proteins with compound/fragment libraries using automated liquid handling systems; process samples in batches via the NMR sample preparation workstation to ensure standardized binding reactions.
3. NMR Detection & Data Collection: Perform high-field NMR testing on incubated samples, collect 1D/2D NMR spectra, and conduct preliminary quality control to filter invalid spectral data and ensure the validity of detection results.
4. Hit Identification & Comprehensive Reporting: Analyze spectral perturbations and binding signals with professional NMR data analysis software to identify positive hit compounds; quantify binding affinity, characterize binding sites, filter false positives, and deliver a detailed screening report with hit structures, binding data and optimization recommendations.

PharmaAnalytica's Technology Platfom

Advantages of PharmaAnalytica's NMR Hit Screening Services

Target-Adaptive Customization

Develops tailored screening protocols for different target types, library sizes and research goals, meeting personalized screening needs for diverse drug discovery projects.

Flexible Platform Compatibility

Integrates smoothly with mainstream early drug discovery screening platforms, forming a multi-dimensional hit discovery system to enhance screening comprehensiveness and hit quality.

Strict Quality Assurance

Implements full-process quality control, standardized operating procedures and reproducible experimental conditions to ensure reliable, traceable screening data.

End-to-End Follow-Up Support

Provides hit validation, fragment evolution, SAR analysis and lead optimization services, closing the loop from initial hit discovery to preclinical drug development.

Backed by STEMart's robust R&D capabilities and PharmaAnalytica's deep expertise in early drug discovery, our NMR Spectroscopy hit screening services offer a label-free, high-reliability solution for identifying novel bioactive hits. We help clients overcome limitations of traditional screening, unlock high-value therapeutic candidates, and accelerate the pace of innovative drug research and development.